Osteoarthritis of the Knee Pain Study Using a CBD and THC Sublingual Tablet
Status:
Recruiting
Trial end date:
2020-07-15
Target enrollment:
Participant gender:
Summary
This study is a prospective Phase 2, drug controlled, open-label study to evaluate the safety
and efficacy of Pure Green sublingual tablets for the treatment of pain associated with
osteoarthritis of the knee.